Latest News

Fluorescent compounds allow clinicians to visualize Alzheimer's disease as it progresses

What if doctors could visualize all of the processes that take place in the brain during the development and progression of Alzheimer's disease? Such a window would provide a powerful aid for diagnosing the condition. Now, researchers have developed a new class of imaging agents that enables them to visualize tau protein aggregates, a pathological hallmark of Alzheimer's disease and related neurodegenerative disorders, directly in the brains of living patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Microexons: Small fragments of genes, essential for neuron maturation

  • Insomnia can predict the appearance of back pain in adults

  • Parkinson's: Small molecules researched for the regeneration of dopaminergic neurons

  • Why some antidepressants may initially worsen symptoms

  • Autism, intellectual disability studied in quest for new treatment approaches

  • Tackling neurotransmission precision

  • Of bugs and brains: Striking similarities in brain structures across invertebrates

  • Neuro-oncologists discover cancer cells can burn acetate for fuel

  • Parkinson's disease reverted at experimental stage

  • The dementia that is not Alzheimer's disease

  •